Background
==========

Screening for increased waist circumference and hypertriglyceridemia (the hypertriglyceridemic-waist phenotype) is an inexpensive approach to identify patients at risk of coronary artery disease in apparently healthy individuals who may be at increased risk of type 2 diabetes and coronary heart disease because of an excess of intra-abdominal (visceral) fat. We examined the relationship between the hypertriglyceridemic-waist and selected cardiometabolic risk factors in HIV individuals.

Methods
=======

The HW phenotype was defined as a waist circumference of 90 cm or more and a triglyceride level of 2.0 mmol/L or more in men, and a waist circumference of 85 cm or more and a triglyceride level of 1.5 mmol/L or more in women. Using these threshold values a total of 2322 patients (841 women and 1481 men) with HIV aged 18-75 years were divided into 4 groups: Low TG/Low WC, High TG/Low WC, Low TG/High WC, High TG/High WC. Continuous variables were analyzed using ANOVA or Kruskal-Wallis test where appropriate; categorical variables were compared using X2-test. The relationship between the HW and cardiometabolic risk assessed with Framingham risk score (FRS) was analyzed using multivariable logistic regression analyses.

Results
=======

Compared with patients who had a waist circumference and triglyceride level below the threshold values, those with the HW phenotype had higher visceral adipose tissue (P\<0.001), higher prevalence of hypertension and the metabolic syndrome (P\<0.001), higher levels of total and LDL-cholesterol (P\<0.001), lower levels of high-density lipoprotein cholesterol (P\<0.001), and higher values of HOMA-insulin resistance (P\<0.001) as shown in Table [1](#T1){ref-type="table"}.

                                          Low TG/Low WC       High TG/Low WC      Low TG/High WC      High TG/High WC     P value
  --------------------------------------- ------------------- ------------------- ------------------- ------------------- ----------
  n (%)                                   592 (25.50)         856 (36.86)         311 (13.39)         563 (24.25)         \-
                                                                                                                          
  DEMOGRAPHICS                                                                                                            
                                                                                                                          
  Women, n (%)                            284 (47.9)          245 (28.62)         145 (46.62)         167 (29.66)         \< 0.001
                                                                                                                          
  Age mean (± S)                          43.3 (6.7)          44.4 (6.6)          45.4 (7.7)          46.9 (7.8)          \< 0.001
                                                                                                                          
  Physical activity, n (%)                232 (39.19)         282 (32.94)         103 (33.12)         152 (27.00)         \< 0.001
                                                                                                                          
  Smoke (\> 10 cigs/day), n (%)           187 (31.59)         285 (33.29)         73 (23.47)          165 (29.31)         0.010
                                                                                                                          
  Alcohol consumption, n (%)              270 (45.61)         363 (42.41)         154 (49.52)         279 (49.56)         0.032
                                                                                                                          
  ANTHROPOMETRICS                                                                                                         
                                                                                                                          
  BMI mean (± SD)                         21.2 (2.2)          21.7 (2.3)          26.3 (3.9)          27.1 (3.8)          \< 0.001
                                                                                                                          
  VAT cm^3^, median (IQR)                 75 (49; 103)        100 (67; 138)       136 (101; 194)      172 (125; 236)      \< 0.001
                                                                                                                          
  Waist Circumference cm, median (IQR)    79 (75; 83)         81 (77; 85)         94 (90; 98)         95 (91; 101)        \< 0.001
                                                                                                                          
  Hip Circumference cm, median (IQR)      87 (83; 90)         86 (83; 89)         94 (91; 97)         94 (90.5; 98)       \< 0.001
                                                                                                                          
  Thigh Circumference cm, median (IQR)    45 (42.5; 48)       45 (43; 48)         49 (46; 52)         49 (46; 52)         \< 0.001
                                                                                                                          
  \% of Leg Fat, median (IQR)             12.6 (7.2; 19.9)    7.7 (5.6; 12.7)     18.1 (12.5; 26.2)   14.0 (9.9; 21.1)    \< 0.001
                                                                                                                          
  HIV history                                                                                                             
                                                                                                                          
  IDU n (%)                               201 (33.95%)        286 (33.41%)        99 (31.83%)         151 (26.82%)        \< 0.001
                                                                                                                          
  CD4+ Nadir median (IQR)                 181 (78; 260)       154 (59; 260)       189 (90; 290)       171.5 (63; 260)     0.014
                                                                                                                          
  CD4+ Current median (IQR)               499.5 (370; 672)    523 (364; 700)      492 (360; 658)      543.5 (375; 737)    0.113
                                                                                                                          
  VL undetectable n (%)                   363 (61.32)         492 (57.48)         190 (61.09)         329 (58.44)         0.432
                                                                                                                          
  Months of PI exposure median (IQR)      24 (0; 60)          35.5 (8; 69.5)      30 (0; 58)          39 (9;7269)         0.005
                                                                                                                          
  Months of NNRTI exposure median (IQR)   16 (0; 45)          18 (0; 48)          17 (0; 49)          16 (0; 46)          0.445
                                                                                                                          
  CARDIOVASCULAR                                                                                                          
                                                                                                                          
  Framingham risk median (IQR)            2 (1; 5)            6 (2; 10)           2 (1; 6)            6 (2; 12)           \< 0.001
                                                                                                                          
  Hypertension, n (%)                     131 (22.13)         302 (35.28)         119 (38.26)         259 (46.00)         \< 0.001
                                                                                                                          
  Albuminuria, n (%)                      38 (6.42)           84 (9.81)           24 (7.72)           59 (10.48)          \< 0.001
                                                                                                                          
  LIPID METABOLISM                                                                                                        
                                                                                                                          
  Triglycerides median (IQR), mmol/L      1.03 (0.81; 1.27)   2.32 (1.87; 3.41)   1.10 (0.89; 1.30)   2.37 (1.85; 3.34)   \< 0.001
                                                                                                                          
  Total cholesterol mean (± SD), mmol/L   4.43 (1.09)         5.05 (1.22)         4.55 (1.10)         5.17 (1.30)         \< 0.001
                                                                                                                          
  HDL mean (± SD), mmol/L                 1.36 (0.44)         1.05 (0.42)         1.33 (0.41)         1.06 (0.30)         \< 0.001
                                                                                                                          
  LDL mean (± SD), mmol/L                 2.70 (0.84)         3.02 (1.03)         2.83 (0.91)         3.09 (1.01)         \< 0.001
                                                                                                                          
  ApoA1 mean (± SD), mg/dL                148.7 (32.6)        137.5 (26.8)        149.9 (29.8)        139.7 (27.0)        \< 0.001
                                                                                                                          
  ApoB mean (± SD), mg/dL                 85.6 (23.4)         108.8 (29.0)        90.3 (24.3)         110.3 (27.3)        \< 0.001
                                                                                                                          
  HOMA-IR median (IQR)                    2.25 (1.39; 3.38)   3.07 (2.04; 5.01)   3.26 (2.21; 5.13)   4.31 (2.74; 6.68)   \< 0.001

The FRS (median 10, range 5;16) was also highest in those with the HW phenotype (P\<0.001). These observations were true independent of gender and remained significant after statistical control for illicit drug use, insulin resistance, antiretroviral therapy exposure, leg fat, and proteinuria as shown in image 1. Figure [1](#F1){ref-type="fig"}
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Conclusions
===========

Among HIV patients from an Italian monocentric cohort, the HW phenotype was associated with a deteriorated cardiometabolic risk profile and an increased FRS. It is suggested that the simultaneous measurement and interpretation of waist circumference and fasting triglyceride could also be used among HIV patients as an inexpensive tool to identify patients with excess visceral fat and with related cardiometabolic abnormalities.
